offline
Pfizer (PFE) Beats Q3 Earnings and Revenue Estimates
Pfizer (PFE) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.78 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 19.05%. A quarter ago, it was expected that this drugmaker would post earnings of $0.77 per share when it actually produced earnings of $0.80, delivering a surprise of 3.90%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Pfizer, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $12.68 billion for the quarter ended September 2019, surpassing the Zacks Consensus Estimate by 4.38%. This compares to year-ago revenues of $13.30 billion.
...
https://finance.yahoo.com/news/pfizer-pf...12709.html
![[Bild: PFEc1dl1420.png]](https://finviz.com/publish/102919/PFEc1dl1420.png)
Pfizer (PFE) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.78 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 19.05%. A quarter ago, it was expected that this drugmaker would post earnings of $0.77 per share when it actually produced earnings of $0.80, delivering a surprise of 3.90%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Pfizer, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $12.68 billion for the quarter ended September 2019, surpassing the Zacks Consensus Estimate by 4.38%. This compares to year-ago revenues of $13.30 billion.
...
https://finance.yahoo.com/news/pfizer-pf...12709.html
__________________
